AAAAAA
Results: 1-25/35
Authors:
Maya, R
Balass, M
Kim, ST
Shkedy, D
Leal, JFM
Shifman, O
Moas, M
Buschmann, T
Ronai, Z
Shiloh, Y
Kastan, MB
Katzir, E
Oren, M
Citation: R. Maya et al., ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage, GENE DEV, 15(9), 2001, pp. 1067-1077
Authors:
Weingarten, MA
Yaphe, J
Blumenthal, D
Oren, M
Margalit, A
Citation: Ma. Weingarten et al., A comparison of videotape and audiotape assessment of patient-centredness in family physicians' consultations, PAT EDUC C, 45(2), 2001, pp. 107-110
Authors:
Zalel, Y
Cohen, SB
Oren, M
Seidman, DS
Zolti, M
Achiron, R
Goldenberg, M
Citation: Y. Zalel et al., Sonohysterography for the diagnosis of residual trophoblastic tissue, J ULTR MED, 20(8), 2001, pp. 877-881
Authors:
Sadot, E
Geiger, B
Oren, M
Ben-Ze'ev, A
Citation: E. Sadot et al., Down-regulation of beta-catenin by activated p53, MOL CELL B, 21(20), 2001, pp. 6768-6781
Authors:
Damalas, A
Kahan, S
Shtutman, M
Ben-Ze'ev, A
Oren, M
Citation: A. Damalas et al., Deregulated beta-catenin induces a p53-and ARF-dependent growth arrest andcooperates with Ras in transformation, EMBO J, 20(17), 2001, pp. 4912-4922
Authors:
Strano, S
Munarriz, E
Rossi, M
Castagnoli, L
Shaul, Y
Sacchi, A
Oren, M
Sudol, M
Cesareni, G
Blandino, G
Citation: S. Strano et al., Physical interaction with Yes-associated protein enhances p73 transcriptional activity, J BIOL CHEM, 276(18), 2001, pp. 15164-15173
Authors:
Oren, M
Citation: M. Oren, Tumor suppressor perspective - Introduction, EXP CELL RE, 264(1), 2001, pp. 1-1
Authors:
Goetz, AW
van der Kuip, H
Maya, R
Oren, M
Aulitzky, WE
Citation: Aw. Goetz et al., Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells, CANCER RES, 61(20), 2001, pp. 7635-7641
Authors:
Reinstein, E
Scheffner, M
Oren, M
Ciechanover, A
Schwartz, A
Citation: E. Reinstein et al., Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue, ONCOGENE, 19(51), 2000, pp. 5944-5950
Authors:
Maya, R
Oren, M
Citation: R. Maya et M. Oren, Unmasking of phosphorylation-sensitive epitopes on p53 and Mdm2 by a simple Western-phosphatase procedure, ONCOGENE, 19(28), 2000, pp. 3213-3215
Authors:
de Rozieres, S
Maya, R
Oren, M
Lozano, G
Citation: S. De Rozieres et al., The loss of mdm2 induces p53 mediated apoptosis, ONCOGENE, 19(13), 2000, pp. 1691-1697
Authors:
Blander, G
Zalle, N
Leal, JFM
Bar-Or, RL
Yu, CE
Oren, M
Citation: G. Blander et al., The Warner syndrome protein contributes to induction of p53 by DNA damage, FASEB J, 14(14), 2000, pp. 2138-2140
Authors:
Zalel, Y
Seidman, DS
Oren, M
Achiron, R
Gotlieb, W
Mashiach, S
Goldenberg, M
Citation: Y. Zalel et al., Sonographic and clinical characteristics of struma ovarii, J ULTR MED, 19(12), 2000, pp. 857-861
Authors:
Ries, S
Biederer, C
Woods, D
Shifman, O
Shirasawa, S
Sasazuki, T
McMahon, M
Oren, M
McCormick, F
Citation: S. Ries et al., Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19(ARF), CELL, 103(2), 2000, pp. 321-330
Authors:
Bar-Or, RL
Maya, R
Segel, LA
Alon, U
Levine, AJ
Oren, M
Citation: Rl. Bar-or et al., Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study, P NAS US, 97(21), 2000, pp. 11250-11255
Authors:
Amson, R
Lassalle, JM
Halley, H
Prieur, S
Lethrosne, F
Roperch, JP
Israeli, D
Gendron, MC
Duyckaerts, C
Checler, F
Dausset, J
Cohen, D
Oren, M
Telerman, A
Citation: R. Amson et al., Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice, P NAS US, 97(10), 2000, pp. 5346-5350
Authors:
Strano, S
Munarriz, E
Rossi, M
Cristofanelli, B
Shaul, Y
Castagnoli, L
Levine, AJ
Sacchi, A
Cesareni, G
Oren, M
Blandino, G
Citation: S. Strano et al., Physical and functional interaction between p53 mutants and different isoforms of p73, J BIOL CHEM, 275(38), 2000, pp. 29503-29512
Authors:
Oren, M
Rotter, V
Citation: M. Oren et V. Rotter, Introduction: p53 - the first twenty years, CELL MOL L, 55(1), 1999, pp. 9-11
Authors:
Juven-Gershon, T
Oren, M
Citation: T. Juven-gershon et M. Oren, Mdm2: The ups and downs, MOL MED, 5(2), 1999, pp. 71-83
Authors:
Unger, T
Sionov, RV
Moallem, E
Yee, CL
Howley, PM
Oren, M
Haupt, Y
Citation: T. Unger et al., Mutations in serines 15 and 20 of human p53 impair its apoptotic activity, ONCOGENE, 18(21), 1999, pp. 3205-3212
Authors:
Blandino, G
Levine, AJ
Oren, M
Citation: G. Blandino et al., Mutant p53 gain of function: differential effects of different p53 mutantson resistance of cultured cells to chemotherapy, ONCOGENE, 18(2), 1999, pp. 477-485
Authors:
Oren, M
Vousden, KH
Citation: M. Oren et Kh. Vousden, Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments, SCIENTIST, 13(12), 1999, pp. 11-11
Authors:
Zeng, XY
Chen, LH
Jost, CA
Maya, R
Keller, D
Wang, XJ
Kaelin, WG
Oren, M
Chen, JD
Lu, H
Citation: Xy. Zeng et al., MDM2 suppresses p73 function without promoting p73 degradation, MOL CELL B, 19(5), 1999, pp. 3257-3266
Authors:
Elkeles, A
Juven-Gershon, T
Israeli, D
Wilder, S
Zalcenstein, A
Oren, M
Citation: A. Elkeles et al., The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor, MOL CELL B, 19(4), 1999, pp. 2594-2600
Authors:
Unger, T
Juven-Gershon, T
Moallem, E
Berger, M
Sionov, RV
Lozano, G
Oren, M
Haupt, Y
Citation: T. Unger et al., Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2, EMBO J, 18(7), 1999, pp. 1805-1814